Dima Shulkin: Comparing HALP and PIV for Mortality Prediction in ACS
Dima Shulkin, Co-Founder and CTO at RobotDreams GmbH, shared a post on LinkedIn about a recent article by Azmi Eyiol, published in Journal of Clinical Medicine, adding:
“A new multicenter study in acute coronary syndrome puts two simple blood-based scores under the microscope: PIV, a combined immune-inflammation value, and HALP, a score built from hemoglobin, albumin, lymphocytes and platelets.
In 1.134 hospitalized patients, HALP predicted mortality better than PIV, with an AUROC of 0.722 versus 0.619, meaning it separated higher-risk from lower-risk patients more reliably.
The striking part is that this signal came from routine admission labs, not from a complex new test.”
Title: Pan-Immune-Inflammatory Value (PIV) and HALP Score as Independent Prognostic Indicators in Acute Coronary Syndrome Patients
Authors: Azmi Eyiol, Hatice Eyiol, Ahmet Yilmaz, Hasan Sari
Stay updated with Hemostasis Today.
-
Sep 28, 2026, 18:48Orly Leiva: Rethinking JAK Inhibitor Cardiovascular Safety in MPNs
-
Sep 28, 2026, 18:42Wael Saad: Honored to Be Part of Portal and Mesenteric Vein Thrombosis Session at CIRSE 2026
-
Sep 28, 2026, 18:35Alejandro González Veliz: The Unbroken Connection Between Heart and Brain
-
Sep 28, 2026, 16:43Scott Sutton: Community and Connection in Immune Thrombocytopenia
-
Sep 28, 2026, 16:24Pankti Solanki: ISBT Recognized JAMA as the 49th Human Blood Group System
-
Sep 28, 2026, 15:52Kassa Tameru: Antithrombotic Management in GI Bleeding and Elective Endoscopy
-
Sep 28, 2026, 15:51Chengappa Kavadichanda: How Do aPLs Change Over Time in Early Lupus?
-
Sep 28, 2026, 15:18Linda Shore-Lesserson: Celebrating 25 Years of PBM at the SABM Meeting
-
Sep 28, 2026, 14:45Access Real-Time Bleeding Disorder Guidelines with the New WFH Resource Hub – WFH